Village Super Market (VLGE.A) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 May, 2026Executive summary
Annual meeting scheduled for December 12, 2025, will be held virtually, allowing shareholders to attend, vote, and submit questions online.
Shareholders will vote on electing nine directors and ratifying KPMG LLP as independent auditors for fiscal 2026.
The company is classified as a "controlled company" under NASDAQ rules due to the Sumas Family Group's voting power.
Proxy materials and annual reports are available online, and shareholders can vote by internet, phone, or mail.
Voting matters and shareholder proposals
Proposals include electing nine directors and ratifying KPMG LLP as independent auditors.
Directors are elected by plurality; auditor ratification requires a majority of votes cast.
Shareholder proposals for the 2026 meeting must be submitted by June 30, 2026; director nominations by October 26, 2025.
Board of directors and corporate governance
Board consists of nine nominees, all current directors, with extensive experience in retail, finance, technology, and philanthropy.
The company does not have a majority of independent directors or independent nominating/compensation committees due to its controlled status.
Board held seven meetings in fiscal 2025, with all directors attending at least 75% of meetings.
Executive Committee authorized to act on corporate policies and performance.
Shareholders may submit director nominations and communicate with the board via written correspondence.
Latest events from Village Super Market
- Sales and net income grew in fiscal 2024, with strong digital sales and margin improvement.VLGE.A
Q4 202413 May 2026 - Net income grew 24% and sales rose 3.2%, driven by digital and remodeled store growth.VLGE.A
Q3 202513 May 2026 - Net income grew 12% to $56.4M on higher sales and digital growth, with improved expense ratios.VLGE.A
Q4 202513 May 2026 - Shareholders will vote on director elections and auditor ratification at the December 2024 meeting.VLGE.A
Proxy filing13 May 2026 - Q2 net income up 17% to $16.9M, sales up 4.2%, and digital sales up 9% year-over-year.VLGE.A
Q2 202513 May 2026 - Sales up 3.2% and net income at $9M, with digital sales growth and new store openings driving results.VLGE.A
Q3 202413 May 2026 - Vote on nine directors and auditor ratification at the December 2025 annual meeting.VLGE.A
Proxy filing13 May 2026 - Annual meeting to elect directors, ratify auditors, and implement leadership transitions.VLGE.A
Proxy filing13 May 2026 - Net income rose 11% on 4% sales growth, with strong digital and pharmacy performance.VLGE.A
Q1 202513 May 2026